Losartan and Emotional Memory
NCT03763409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53
Last updated 2018-12-06
Summary
This study explores the effects of single-dose losartan (50mg) versus identical placebo capsule on emotional memory and learning in healthy volunteers.
Conditions
- Memory
- Learning
Interventions
- DRUG
-
Losartan Potassium
active drug
- OTHER
-
placebo
placebo
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-01
- Primary Completion
- 2018-09-28
- Completion
- 2018-09-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
NCT04033419 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Effect of Lorazepam on Brain Activity Measured by Magnetoencephalograpy (MEG) and Electroencephalography (EEG)
NCT01272778 ·Status: UNKNOWN ·Phase: NA
-
Influence of Luteolin for Two Weeks on Memory in Healthy Subjects
NCT06047899 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
NCT01354691 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.
NCT01117948 ·Status: TERMINATED ·Phase: PHASE2
-
HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
NCT02013310 ·Status: COMPLETED ·Phase: PHASE2
-
Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment
NCT00691808 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity
NCT05834231 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Reversing Corticosteroid Induced Memory Impairment
NCT01142310 ·Status: COMPLETED ·Phase: PHASE4
-
The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms
NCT01780519 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
NCT03765762 ·Status: COMPLETED ·Phase: PHASE2
-
INTERCEPTOR Project: From MCI to Dementia
NCT03834402 ·Status: COMPLETED
-
Memantine for Agitation in Dementia
NCT00371059 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
NCT00857649 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Seltorexant in Participants With Probable Alzheimer's Disease
NCT05307692 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue
NCT02996916 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
NCT01429623 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function
NCT01734200 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neuromodulation and Language Acquisition (Stage Ib)
NCT00102856 ·Status: SUSPENDED ·Phase: PHASE4
-
Treatment of Language and Memory in Patients With Alzheimer's Disease
NCT00593372 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease
NCT02991235 ·Status: UNKNOWN ·Phase: NA
-
16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
NCT01948791 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
NCT04711486 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
NCT00322153 ·Status: COMPLETED ·Phase: PHASE3